Recently, a peak at 1.28 ppm in proton magnetic resonance spectroscopy ( 1 H-MRS) of neural stem cells (NSCs) was introduced as a noninterventional biomarker for neurogenesis in vivo. This would be an urgently needed requisite for translational studies in humans regarding the beneficial role of adult neurogenesis for the structural and functional integrity of the brain. However, many concerns have risen about the validity of the proposed signal as a specific marker for NSCs. The peak has also been related to cell-type-independent phenomena such as apoptosis or necrosis. Thus, we compared the 1.28-ppm peak in various immature stem cell populations, including embryonic stem cells, mouse embryonic fibroblasts, embryonic stem cell-and induced pluripotent stem cell-derived NSCs, ex vivo isolated embryonic NSCs, as well as mature and tumor cell types from different germ layers. To correlate the integral peak intensity with cell death, we induced both apoptosis with camptothecin and necrosis with sodium azide. A peak at 1.28 ppm was found in most cell types, and in most, but not all, NSCH cultures, demonstrating no specificity for NSCs. The intensities of the 1.28-ppm resonance significantly correlated with the rate of apoptosis, but not with the rate of necrosis, cell cycle phase distribution, cell size, or type. Multiple regression analysis displayed a significant predictive value of the peak intensity for apoptosis only. In this context, its specificity for apoptosis as a major selection process during neurogenesis may suggest this resonance as an indirect marker for neurogenesis in vivo.
Introduction
A nimal research provides evidence for both the importance of adult neurogenesis for the structural integrity and performance of the central nervous system and at the same time for the responsiveness of neural stem cells (NSCs) to internal and external (environmental) stimuli. [1] [2] [3] Thus, neurogenesis is believed to be a promising therapeutic target for cell replacement strategies in both brain injury and neurodegenerative diseases. [4] [5] [6] [7] However, translational research to reproduce these findings in humans has largely been prevented by the lack of an adequate method to study neurogenesis in vivo. Whereas post mortem bromodeoxyuridine (BrdU) incorporation studies in cancer patients point to the existence of some postnatal neurogenesis in the brain, 8, 9 a tool for studying the physiological regulation of human neurogenesis is still unavailable. In 2007, a study by Manganas and colleagues proposed that not only NSCs possess a cell type-specific peak at 1.28 ppm in proton magnetic resonance spectroscopy ( 1 H-MRS), but also that this peak is suited to study physiological and pathological regulation of neurogenesis in both animals and humans in vivo. 10 Since this publication offered the so far missing link for translational research, it received a high level of attention, but at the same time it raised several concerns on both the methodological level and the biological significance. On the one hand, it was questioned whether the singular value decomposition (SVD) spectral analysis used in this study was suitable for generating reliable data, and, on the other hand, the cell type specificity of the signal was heavily debated.
The proposed NSC-specific proton magnetic resonance spectroscopy ( 1 H-MRS) peak has long been known as a signal derived from methylene groups in fatty acyl residues in mobile lipids, most likely located in intracellular lipid bodies. [15] [16] [17] More importantly, there is substantial information available on the correlation of these intracellular lipid bodies and their associated 1 H-MRS signal to different biological phenomena, particularly apoptosis. 16, 18 It is unclear from the above-mentioned study by Manganas and coworkers how the proposed NSC-specific signal at 1.28 ppm is related to the already known biological significance of methylene group-derived lipid resonances and whether it can be distinguished from these signals at all. Indeed, a recently published study rather put the cell specificity of this signal and its potential distinction from methylene groupderived resonances in doubt. 14 Together, it remains enigmatic whether there is a specificity of the signal at 1.28 ppm in 1 H-MRS for NSCs or whether this signal or adjacent/overlapping signals are related to various forms of cell degradation or death independent of the cell type. Thus, we studied the relevance of this peak using high-field 1 H-MRS in a wide set of undifferentiated and maturely differentiated cell populations of all germinal sheets and quantitatively correlated it with the rate of apoptosis or necrosis as different forms of cell death.
Materials and Methods

Cell culture
Cells were cultured according to established protocols for the respective cell type. Fetal cortical NSCs were isolated from embryonic C57/BL6 mouse brain at embryonic day 14 (E14) and cultured in neurospheres as described in Milosevic et al. 19 These neurosphere cultures were highly enriched NSC cultures with 91.4 AE 9.2% of nestin þ NSCs (n ¼ 5). The protocol used for mixed primary neural cultures containing both glial and neuronal cells was reported in Freudenberg et al. 20 Pure astrocytic cultures were prepared according to Song et al., 21 embryonic stem (ES) cells and ES-cell derived NSCs according to Kawasaki et al., 22 and induced pluripotent stem (iPS) cell-derived NSCs and embryonic fibroblasts as described in Kim et al. 23 MN9D cells were grown according to Heller et al. 24 and melanoma and glioma cell lines according to Kirsch et al. 25 and Uo et al., 26 respectively. Note that all cells are of murine origin.
Camptothecin and sodium azide treatment
For induction of apoptosis, camptothecin (Sigma-Aldrich, Hamburg, Germany) was added to the respective cultures at 5 mM final concentration 18 hr before spectroscopic analysis, as described in Uo et al. 27 Necrosis was induced by sodium azide (Sigma-Aldrich) 3 hr before analysis at final concentrations of 46, 115, and 230 mM according to the specifications described in Lizard et al. 28 Cell preparation for spectroscopic analysis Cells were converted into a single-cell suspension by treatment with 0.05% trypsin-EDTA (Invitrogen, Karlsruhe, Germany) for 10 min at 378C, followed by a 10-min treatment with a mixture of 40 mg of DNase, 150 mg of trypsin inhibitor, and 1.81 g of MgSO 4 (all from Sigma-Aldrich) and subsequent trituration with fire-polished glass pipettes. Cells were then washed twice with phosphate-buffered saline (PBS) and adjusted to a concentration of 10Â10 6 cells/mL. To 500 mL of the cell preparation, 50 mL of trimethylsilylpropionate (TMP) in pure deuterium oxide (D 2 O) was added as a frequency lock and internal standard (both from SigmaAldrich). Cell suspensions were transferred to nuclear magnetic resonance (NMR) sample tubes (VWR International, Darmstadt, Germany) and kept on ice until 1 H-MRS analysis.
NMR acquisition
One-dimensional 1 H-NMR spectra of the aqueous suspensions of cells (0.55 mL, pH 7.25) containing 10% D 2 O as a field frequency lock were measured using a 600-MHz Bruker Avance NMR spectrometer (Bruker Biospin, Rheinstetten, Germany). Spectral analysis was conducted using XWinNMR, v. 3.5. In all experiments, the temperature was maintained at 358C and pH at 7.25. The spectra were acquired as free induction decay (FID, 32,768 points in a spectral width of 8,389.3 Hz, readout time of 1.95 sec, repetition time of 2 sec and 128 averages). To minimize the large water peak, the water signal was presaturated with a low-power radiofrequency pulse. 9 Exposure of cell cultures to these MRS conditions did not influence their apoptosis rates (data not shown).
Data processing/spectral analysis
Processing of measured data was performed using the TopSpin software (BRUKER BioSpin, v. 1.3). Before Fourier transformation, FIDs were processed with a line-broadening function of 1.0 Hz. Then 1 H-NMR spectra were phase and baseline corrected for distortions and referenced to trimethylsilylproprionate (TSP; chemical shift 0.00 ppm). No significant broadening of the TSP resonance was detected in the presence of the investigated cells. After peak picking and integration, a deconvolution (mixed line shapes of Lorentzian and Gauss) was performed, followed by the normalization of the individual integral values using the TSP peak (defined constant concentration).
Measuring of apoptosis, cell cycle distribution, and necrosis
Immediately after
1 H-MRS analysis, the cell samples were tested for the respective level of apoptosis and necrosis. Determination of apoptotic cell fraction and cell cycle distribution was carried as described in Nicoletti et al. 29 and Glick et al. 30 Briefly, 1Â10 5 of the total cells measured were washed once with PBS and then resuspended in 300 mL hypotonic lysis buffer (0.1% sodium citrate, 0.1% Triton X-100, 50 mg/mL propidium iodide [Invitrogen, Karlsruhe, Germany]). After an incubation period of 30 min on ice and in the dark, cells were directly analyzed using fluorescenceactivated cell sorting (FACS; LSRII FACS analyzer, Becton & Dickinson, Heidelberg, Germany). Testing for necrosis was performed using the LIVE/DEAD Ò Fixable Dead Cell Stain Kit according to the manufacturer's specifications (L34955, Invitrogen, Karlsruhe, Germany).
Statistical analysis
Statistics were calculated using SPSS software Version 16.0 (SPSS, Chicago, IL). Significant differences between two or 372 LOEWENBRÜ CK ET AL. Figure 1 shows a high-field 1 H-MRS spectrum of a living murine fetal (E14) neurosphere culture of highly purified NSCs as a representative spectrum from the various stem cell populations investigated in this study. The peak of TSP at 0.00 ppm was used as a frequency lock and internal standard for quantitative comparisons between the different samples. Peaks of metabolites characteristic for quickly dividing cell populations, such as choline, were detected in addition to different amino acids (succinate, glutamate, alanine, valine) and lactate as the end product of anaerobic glycolysis. Other studies investigating the chemical footprint of different cell types typically do not work with intact cells, but rather with cell constituents after cell degradation and lyophilization. 31 This approach allows for a much more detailed study of the chemical constituents than is possible by the directly ex vivo spectra recorded in this study. However, it also prevents the analysis of signal changes related to biological activity or the physicochemical environment of different metabolites in intact cells.
We studied 1.28-ppm peak intensities over all major steps of neural development in vitro from pluripotent embryonic stem (ES) cells over NSCs of various origins (ES cell-and induced pluripotential stem [iPS] cell-derived NSCs, primary fetal cortical NSCs) to mature neural cell cultures, including maturely differentiated NSCs, primary mixed cortical cultures (consisting of glial and neuronal cell types), and primary astrocytes. The peak of interest at 1.28 ppm could readily be detected in the spectra of all mentioned cell populations without any systematic change of integral peak intensity with respect to the developmental stage of the cell population ( Figs. 2A,B) . Moreover, glioma cells and the MN9D cell line as well as nonneural cell types, such as embryonic fibroblasts or melanoma cells, also expressed the 1.28-ppm peak clearly above the background noise level (Figs. 2A,B) . Because the peak at 1.28 ppm as a lipid-derived signal could be related to differences in the net lipid content of cells of different sizes, we compared peak intensities and cell diameters, not finding any correlation between these two parameters ( Fig. 2C ; r ¼ 0.14, p ¼ 0.54, Pearson correlation coefficient). Besides this lack of correlation with cell size, qualitative and quantitative comparisons of 1.28-ppm peak intensities with cell type neither revealed any specificity of the peak for undifferentiated stem cells nor for neural stem cells and their progeny (Fig. 2) .
Effects of apoptosis and cell cycle distribution on peak intensity at 1.28 ppm in various cell systems
In contrast to the unspecific nature of the 1.28-ppm peak with respect to the cell type and its developmental stage, comparison of the integral signal intensity with apoptosis showed a clear correlation of peak intensity with spontaneous apoptosis rate. In untreated cell cultures, cell types with a low integral intensity of the peak at 1.28 ppm, such as astrocytic or primary cortical cultures, were without exception those that had low levels of spontaneous apoptosis ( Fig.  2A,B) . Thus, we quantitatively measured the correlation between peak intensities at 1.28 ppm and apoptotic cell death in various cell types. Apoptosis was induced by an 18-hr treatment with camptothecin, a frequently used potent inductor of apoptosis in a variety of cell types. 32 The level of apoptosis was measured by the intensity of the sub-G 1 peak
FIG. 1.
Representative high-field proton magnetic resonance spectroscopy ( 1 H-MRS) spectrum of a neurosphere culture of embryonic neural stem cells (NSCs) derived from embryonic cortical tissue dated embryonic day 14 (E14). The lower trace represents the original spectrum whereas the upper trace shows its computed fit, which was used for quantitative analysis. Besides typical metabolites, such as choline, succinate, glutamate, alanine, lactate, and valine, lipid-derived signals are detected both around 1.28 ppm (arrowhead) and between 0.88 and 0.94 ppm (two arrowheads), displaying the typical broader shape of lipid-derived peaks. Whereas the peak at 1.28 ppm has been described to originate from mobile methylene (CH2) groups in membrane-associated lipids organized in so called internal lipid bodies, the peaks between 0.88 and 0.94 ppm have been related to methyl (CH3) groups in membrane-associated lipids. The intensity of both signals is known to change in a variety of biological processes, such as apoptosis, cell degeneration in general, or inflammation. The peak at 0.00 ppm is generated by trimethylsilylpropionate (TSP) and used as an internal standard.
in propidium iodide (PI)-FACS analysis of degraded hypodiploid nuclei as a common final path of different forms of apoptosis (Fig. 3A) . 29 Treatment with camptothecin resulted in a highly significant increase of the apoptotic culture rate only in some cultures (Figs. 3 and 4A-C), whereas other cell types were resistant to the treatment and showed no significant increase in apoptosis (Figs. 3 and 4D-F) . Consistent with the observation in untreated cells, significant increase of 1.28-ppm peak intensities was exclusively observed in cell cultures with significant induction of apoptosis (Fig. 4) .
We then calculated statistical correlations between all cell types (treated with camptothecin or untreated) and the measured apoptotic rate. Multiple linear regression analysis using different exclusion criteria revealed that the peak intensity at 1.28 ppm was significantly determined by the level of apoptosis only ( 
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not by any cell type ( Fig. 5B ; p > 0.05 for all), cell diameter ( Fig. 5C ; p ¼ 0.45) or treatment with camptothecin (not shown; p ¼ 0.23). Previous reports suggested that the ratio between methylene-derived signals around 1.28 ppm and methyl groups-derived signals around 0.9 ppm provides a reliable marker for apoptosis. 18 The results of linear regression modeling of the methylene/methyl (CH2/CH3) ratio resulted in similar results for the predictive value of apoptosis as in the respective analysis comparing 1.28-ppm peak integral intensities only with the level of apoptosis (Fig. 5D) . However, using the CH2/CH3 ratio, an accompanying predictive value for the CH2/CH3 ratio could be found in addition to apoptosis for ES cell type, but not for all other cell types, cell diameter, or treatment with camptothecin (results of multiple Despite the close interaction between apoptosis and the cell cycle and the observation of a significant negative correlation between the proportion of cells in apoptosis and in G 0 /G 1 phase in this study (r ¼ À 0.446, p ¼ 0.001, Pearson correlation), no correlation could be found between the peak intensity at 1.28 ppm and different phases of the cell cycle as distinguished by FACS-based cell cycle analysis ( Fig. 5G-I ; p values for all cell cycle phases >0.05, Pearson correlation). However, the CH2/CH3 ratio as an alternative MRS marker for apoptosis showed a slight negative correlation with the proportion of cells in G 0 /G 1 phase (r ¼ À0.401, p ¼ 0.04, Pearson correlation). 
H-MRS spectra of different cultures of embryonic
NSCs are displayed as a function of their apoptotic rate. The differences in apoptosis either were spontaneous, or induced by an 18-hr treatment with camptothecin (5 mM final concentration). A constant increase in the integral of the peak at 1.28 ppm was detected with increasing fractions of apoptotic cells in the cultures. (C) Mean spectra of various cell types were generated for the untreated samples, as well as for the samples treated with the apoptosis-inducing agent camptothecin and ordered according to their apoptotic rate. Again, samples that had a low spontaneous rate of apoptosis or were resistant to the treatment with camptothecin (astrocytes) displayed integral intensities at 1.28 ppm at the detection limit, whereas cell types with a high spontaneous or chemically induced apopototic rate also had high intensities of the integral of the peak at 1.28 ppm. ES cell, Embryonic stem cell; iPS cell, induced pluripotential cell.
Prediction by the independent variables in this study in a linear regression model was possible for the peak at 1.28 ppm only and not for two other metabolites detected by 1 H-MRS, namely lactate and choline, showing no significant prediction of these metabolites by apoptosis rate, cell type, diameter or treatment (Figs. 5E,F; multiple regression analysis: r 2 ¼ 0.20, p ¼ 0.06 and À0.09, p ¼ 0.78).
Effects of necrosis on peak intensity at 1.28 ppm in fetal cortical NSCs
Methylene group-derived signals in the spectral region at 1.28 ppm had also been suggested to be related to necrosis as an uncontrolled form of cell death. 16 Therefore, we compared the intensities of the peak at 1.28 ppm in fetal cortical NSC cultures with the level of necrosis (Fig. 6) . Necrosis was induced with sodium azide, which deprives cells of their energy supply by blocking cytochrome c oxidase. 29 Although this treatment resulted in a nearly complete induction of necrosis (93.5 AE 2.2% in the samples treated with the highest concentration of 230 mM (n ¼ 4; Fig. 6A,C) , no increase in the 1.28 peak intensity was detected (Fig. 6B,C) . Accordingly, there was no correlation between the peak intensity at 1.28 ppm and the level of necrosis in this cell type ( Fig. 6D ; r ¼ 0.05, p ¼ 0.86, Pearson correlation coefficient).
Discussion
We aimed at understanding the biological relevance of the 1 H-MRS signal at 1.28 ppm in living cells, which was proposed as a NSC-specific signal and how this signal relates to the known biological significance of lipid-derived signals located precisely in this spectroscopic region. 10 Our results did not reveal any correlation of the peak at 1.28 ppm with NSCs or any other cell type tested, but showed a strong correlation of the peak with apoptotic cell death. We also tested the peak intensity at different developmental stages from pluripotent ES or iPS cells over NSCs to differentiated , and glioma cells (C) resulted in a significant induction of apoptosis ( p < 0.01 for all) and was accompanied by a significant induction of integral intensities at 1.28 ppm, the treatment of primary cortical cultures (D), astrocytes (E), and MN9D as a dopaminergic neural cell line (F), either had no effect on the apopotic rate, or to a significance level of p < 0.05 only, accompanied by no increase in integral intensities at 1.28 ppm. (*) Significant different results with p < 0.05; (**)significant results with p < 0.01.
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neuronal cells types, but could not find any specificity for any of these developmental stages. Multiple regression analysis displayed a significant predictive value of the peak intensity for apoptosis only, but not for necrosis, cell size, or cell type. Our data do not support the 1.28-ppm peak in 1 H-MRS as a direct biomarker for NSCs, but its specificity for apoptosis as a major selection process during neurogenesis proposes it as an indirect marker of neurogenesis in vivo.
The results of our study are in line with one previous study on the impact of apoptosis on the peak intensity at 1.28 ppm in NSCs. 14 The authors showed that apoptosis induction by menadione increased the peak intensity in all tested cell types and that it was not present in the absence of apoptosis, but they did not measure the actual apoptosis rate in their cultures and thus were not able to correlate the 1.28-ppm peak intensity with the rate of apoptosis. However, quantification of the apoptosis rate is of great importance because there are large differences in both the spontaneous apoptosis rate and the responsiveness to toxic apoptosis induction between various cell lines (Fig. 4) . 32 The mechanisms 
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leading to the differences in apoptosis rates and sensitivity to apoptotic stressors remain unknown, but are probably at least in part cell-intrinsic processes. Additionally, the high variance in apoptosis rates might also be induced by the cell preparation needed for MRS measurements, whereas MRS itself does not induce apoptosis (see Materials and Methods for details). Our study extended markedly the previous knowledge by measuring peak intensities of a very wide range of cells at very different apoptotic levels (quantified by PI-FACS) and analysis by a linear multiple regression model, which clearly demonstrated that the 1.28-ppm signal is specifically correlated with the level of apoptosis, but not with necrosis, cell size, or cell type.
The discrepancies between the two recent studies and the in vitro studies reported by Manganas and co-workers describing the 1.28-ppm peak as highly enriched and thus specific for NSCs and other neuroectodermal progenitor populations 10 could be related to different rates of apoptosis in the cultures used. We prepared our NSC cultures under close adherence to the protocol provided by Manganas et al. 
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and measured considerable levels of at least 9% of spontaneous apoptosis in these cultures, accompanied by a corresponding signal at 1.28 ppm. Unfortunately, Manganas and co-workers did not measure apoptosis or cell death in their study. Consistently, cell types that were used as negative controls by Manganas and colleagues, such as astrocytes or differentiated neural cell cultures, have a known resistance to spontaneous and induced apoptosis and also displayed a low intensity or absence of the 1.28-ppm peak in our study. 32 The specificity for apoptosis of the peak at 1.28 ppm is further supported by the finding that even NSC cultures with very low levels of cell death do not display the peak at 1.28 ppm.
14 A recent publication focusing on methodological aspects of spectrum analysis did not completely rule out that in the spectral region of interest around 1.28 ppm there are both a NSC-specific peak at low signal intensity and already known peaks derived from mobile methylene groups. 33 However, evidence for the existence of two distinct signals in the same spectral region was neither found by the cited experimental study on cell-specificity of the signal nor by our results.
14 Apoptosis is a proliferation-related event, because cells have to be in the active phases of the cell cycle to undergo programmed cell death. [34] [35] [36] Additional analysis revealed no correlation between the intensity of the peak at 1.28 ppm and other phases of the cell cycle, whereas for the CH2/CH3 ratio a mild negative correlation could be found with the proportion of the cells in G 0 /G 1 phase. However, this correlation was much weaker than the correlation between CH2/CH3 and apoptosis (r ¼ À0.401 versus r ¼ 0.784, Pearson correlation). These data further support that the peak at 1.28 ppm is related primarily to apoptosis, because apoptotic cells have been found in this and other studies to recruit mainly from the cell population in G 0 /G 1 phase, so that the mild negative correlation can be viewed as an indirect effect. 37 Cultures of quickly proliferating cell populations, such as tumor or stem cells, are particularly prone to induction of apoptosis, which can be favored even by scarcity of nutrition or contact inhibition characteristic for quickly proliferating cultures. Thus, there is no need for a second, cell-specific signal in this spectral region to explain the differences in peak intensity observed in different cultures. In our study, NSCs were the most sensitive to spontaneous and toxic induction of apoptosis, and this suffices to explain the high intensity of the peak in NSC cultures. The former study by Ramm and colleagues and our study cannot fully rule out the existence of a NSC-specific signal in the same spectral region subjacent to the apoptosis-related 1.28-ppm peak. 14 This seems however very unlikely, because the peak was not detectable in NSC cultures with very low levels of cell death. 14 Our results are well in line with a considerable number of experimental and clinical studies on the origin and biological significance of the spectroscopic signal from lipid-derived methylene groups. The signal has been linked to an increased mobility of methylene groups in membrane lipids as the result of the conformation of so called internal lipid bodies, a process strongly related to apoptotic cell death, but also to other rather cell type-independent biological processes such as inflammation, malignant proliferation, or necrosis. 16 The link of the signal has been best established for apoptosis and has found entry into clinical diagnostic procedures, such as the evaluation of tumor regression or type. [38] [39] [40] The two tumor cell types studied in the present report, mouse melanoma and glioma cells, were also prone to the induction of apoptosis and depicted a concomitant high peak intensity.
Manganas and co-workers additionally used two models to claim the usefulness of the 1.28-ppm signal for studying NSC behavior in vivo. First, NSCs were transplanted into rat brains and subsequently detected by the peak at 1.28 ppm. However, this paradigm seems to be unsuitable for distinguishing between the in vivo detection of a cell-specific signal and the detection of an apoptosis-derived signal in the same spectral region, because it has been shown that the majority of transplanted cells do not survive the procedure of transplantation (up to 96%) and undergo apoptosis or necrosis. 41 The second model used was electroconvulsive shock treatment as a potent inductor of neurogenesis. This paradigm is not only a potent inductor of NSCs proliferation and their nonfunctional differentiation, but also of apoptotic cell death of the majority of newborn cells, 42, 43 thus it is not able to provide a clear distinction between a NSC-specific and an apoptosis-specific MRS signal. It is noted that these limitations do not necessarily disable the method for studying neurogenesis in vivo, because estimating the rate of apoptosis within the neurogenic niche might be an indirect measure of stem cell turnover or homeostasis as supported by the results of Manganas and co-workers. 10 Together, our study provides evidence that the peak at 1.28 ppm in 1 H-MRS spectra is a specific marker for apoptosis, and its intensity neither correlates with a distinct cell type, such as NSCs, nor with other cellular states, such as necrosis or cell cycle phase distribution. Because the apoptotic cell death is a biological process closely related to stem cell functioning and homeostasis, our results do not exclude a relevance of this signal in studying NSC biology in vivo as reported by Manganas and colleagues. 10 Because in vivo 1 H-MRS provides spatially resolved spectral information, it could be used to obtain indirect information about the regulation and homeostasis of the NSC pool within neurogenic niches by studying the local apoptosis rate.
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